GeneExpression Systems, Inc & Appasani Research Conferences and Educational Institue (ARCEI-US.ORG)
Jontly Presents

Inaugural
Metabolomics-2013 Symposium

on
Diabetes, Obesity & Cardiovascular Diseases - 2013 Meeting

‘Insulin Resistance to Delivery, Body Weight Regulation & Devices’
‘Molecular Cardiology to Biotherapeutics & Stents’

Date: July 10-11, 2013

Scope of the Meeting:

The purpose and scope of this 'Metabolomics Symposium' is to provide a forum for the discussion of the current state of the art in emerging branches of metabolic diseases that includes diabetes, obesity and cardiovascular diseases to develop appropriate biomarkers, therapeutics and devises for better diagnosis and treatment.

Metabolomics Symposium-2013 on ‘Diabetes, Obesity, Cardiovascular Diseases &Devices’will bring together young and established clinicians, researchers from  academia and industry (with diverse backgrounds in cardiology, cardiac surgery, endocrinology, diabetes, obesity research, stem cell biology, molecular/cellular biology, drug discovery and other aspects of metabolic disease biology), and discuss the clinical and drug/device discovery strategies in form of keynote lectures, invited talks, short oral, and poster presentations. Dedicated time allowed for presentation of posters, viewing the exhibits, to know the available cutting-edge reagent, devises and services in the field. The conference should be interesting for graduate students, postdoctoral fellows, professors, clinicians from academia and scientists, directors, chief scientific officers and chief executive officers from biopharmaindustry, as well as for anyone interested in studying cardiac and metabolic functions and their associated diseases. Authorities in the field selected and invited as presenting speakers.

Needless to say that Diabetes, Obesity and Cardio-vascular diseases are the major devastating metabolic syndromes in the westernized and developing world. This is the most important venue to bring together mix of quality presentations by high-caliber speakers and a place to exhibit lucrative medical devises. In this meeting we will bring latest innovations in the intersection of obesity, diabetes and cardiovascular diseases. Novel genome-wide, proteomics and systems biology approaches will be discussed to understand the molecular signaling events involved in diseased processes, and subsequently develop novel drug targets. This meeting will also highlight the cell therapy approaches using stem cells especially in the treatment of diabetes, vessel repair and regeneration. Most importantly, the latest devices and their applications in the delivery of insulin, glucose monitoring, vascular stents and synthetic valves will be discussed.

The venue is a cutting-edge conference facility located in New Research Building at the Harvard University Medical School nuclear campus (that consists of world-renowned teaching hospitals, Brigham & Women’s Hospital, Children’s Hospital, Beth Israel Deaconess Medical Center, Joslin Diabetes Center, Dana-Farber Cancer Institute, Harvard School of Public Health and close by Massachusetts General Hospital). Best Western, The Inn at the Longwood Medical located few blocks from the venue is arranged for accommodation for this meeting participants.

Krishnarao Appasani, PhD., MBA Founder & CEO GeneExpression Systems, Inc Waltham, MA USA

Keynote Speakers:

	Peter Libby, MD. Chief, Division of Cardiovascular Medicine       Mallinckrodt Professor of Medicine & Director of the Reynolds Cardiovascular Clinical Research Center Brigham and Women’s Hospital & Harvard Medical School. Boston, Massachusetts, USA Title: Cardiovascular Disease: Is Inflammation the missing link??
	Evan D. Rosen MD, PhD.  Associate Professor of Medicine, Endocrinology, Diabetes, and Metabolism Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts, USA Title: Epigenetic mechanisms in metabolic health and disease

Other Speakers:

	Barbara E. Corkey, PhD.     Zoltan Kohn Professor of Medicine & Vice Chair for Research-Obesity Research Center Boston University School of Medicine Boston, Massachusetts, USA Title: Redox Regulation of Metabolic Function		Habib Samady, MD, FACC                                      Professor of Medicine, Director Interventional Cardiology & Attending Physician at Emory Clinic Emory University School of Medicine Atlanta, Georgia, USA Title: Predicting Plaque progression in coronary arteries via fluid dynamics
	Leonard P. Guarente, PhD. Novartis Professor of Biology Massachusetts Institute of Technology Cambridge, MA, USA Title: Sirtuins-aging, diseases and circadian control		Da-Zhi Wang, PhD. Associate Professor of Cardiology Children's Hospital Boston & Harvard Medical School Boston, Massachusetts, USA Title: microRNAs in the heart
	Karin Jandeleit-Dahm, MD, PhD, FRACP Professor of Medicine & Head of Diabetes and Kidney Disease Baker IDI Heart and Diabetes Institute Monash University, Australia & University of Hannover, Germany Victoria, Australia Title: Novel targets to treat diabetic complications		Corinth Auld, PhD.                                       Medical Science Liaison Mercodia, Inc. Winston-Salem, NC, USA Title: Biomarker assays for the detection of metabolic diseases
	Zhongdong (John) Huang, PhD. Associate Director of Cell Biology Halozyme Therapeutics Inc. San Diego, CA, USA Title: Recombinant human hyaluronidase PH20 (rHuPH20) accelerates insulin exposure and does not stimulate inflammation		Gregory D. Lewis, MD. Associate Professor of Medicine Harvard Medical School & Associate Director MGH Cardiopulmonary Exercise Laboratory Mass General Hospital Heart Center Boston, Massachusetts, USA Title: Biomarkers/metabolic signatures for cardiovascular diseases
	Donalyn Scheuner, PhD.  Senior Research Scientist Diabetes Drug Hunting Team Eli Lilly & Company Indianapolis, IN, USA Title: Stress signaling in beta cell function and metabolic disease		Maria Cecilia Scimia, MD., PhD. Associate Scientist Center for Translational Medicine, Temple University Philadelphia, PA, USA Title: APJ acts as a dual receptor in cardiac hypertrophy
	Jose C. Florez, MD, PhD. Associate Professor of Medicine Harvard Medical School & Massachusetts General Hospital & Associate Member of the Broad Institute of MIT & Harvard Boston, Massachusetts, USA Title: Genome-wide association studies in the pathophysiology of type 2 diabetes		Dr. Dirk Sartor  Chief Executive Officer Cardiolynx Ltd. Basel, Switzerland Title: One heart, one life, multiple protection
	Yossi Tam, DMD, PhD. Staff Scientist in Neuroendocrinology Section Laboratory of Physiologic Studies NIAAA-National Institutes of Health Bethesda, Maryland, USA Title: The peripheral endocannabinoid/CB1 receptor system: A novel therapeutic target for obesity-related leptin resistance		Mannix Auger-Messier, PhD.                                          Assistant Professor of Medicine University of Sherbrooke Sherbrooke, Québec, Canada Title: The role of DUSP proteins in dilated cardiomyopathy
	Mireille J.M. Serlie, MD, PhD. Professor of Endocrinology and Metabolism Academic Medical Center-University of Amsterdam Amsterdam, The Netherlands Title: The role of serotonin and dopamine in obesity and glucose metabolism		Ting-Ting Hong, MD., PhD.     Postdoctoral Fellow Cardiovascular Research Institute University of California San Francisco San Francisco, CA, USA Title: BIN1, an essential cardiac protein that is also a blood-based biomarker of cardiac reserve
	Bruce L. Riser, PhD.         Director, R&D Pharmaceuticals Baxter Healthcare McGaw Park, IL, USA Title: CCN3 based therapy: Novel prevention and treatment in complications of diabetes and obesity		Benjamin S. Maciejewski        Senior Associate Scientist CVMED Discovery Innovations Pfizer Inc. Cambridge, MA, USA Title: Pharmacological inhibition to examine the role of DGAT1 in rodents and man
	Aaron M. Cypess, MD, PhD, MMSc. Assistant Professor of Medicine Harvard Medical School & Assistant Investigator and Staff Physician Joslin Diabetes Center Boston, Massachusetts, USA Title: A new treatment target for obesity and diabetes - brown adipose tissue		Dr. Hana Koutnikova                       Cardiovascular Health Principal Scientist Danone Research Company Palaiseau, France Title: Functional food as a part of dietary strategy to cardiovascular and metabolic disease management
	Takhar Kasumov, PhD.                                            Staff Member in Gastroenterology & Assistant Professor of Medicine Cleveland Clinic & Lerner College of Medicine Cleveland, OH, USA Title: Ceramide as a mediator of obesity induced atherosclerosis, Heavy water based metabolic labeling approach		Steven E. Cohen, MD.                                              Executive Director of External Scientific Affairs Cardiovascular-Metabolism & Frontiers Daiichi Sankyo, Inc.   Edison, NJ 0, USA Title: Pharma-Academia Collaboration for Enhancing Drug Discovery
	Jun Sonoda, PhD. Scientist of Molecular Biology Genentech, Inc. South San Francisco, California, USA Title: Fat-burning antibody for the treatment of type-2 diabetes		Neil Poloso, Ph.D. Principal Scientist of Biological Sciences Allergan, Inc. Irvine, CA, USA Title: The role of prostamides in the regulation of the adipocyte biology
	Bridget K. Wagner, PhD. Director of Pancreatic Cell Biology Chemical Biology Program The Broad Institute of Harvard and MIT Cambridge, Massachusetts, USA Title: High-throughput screening to identify small-molecule modulators of beta-cell mass		Annie Moisan, PhD.                                      Post-doctoral Scientist Cardiovascular & Metabolism Discovery F. Hoffmann-La Roche Basel, Switzerland Title: Pharmacological induction of a brown phenotype in human stem cell-derived adipocytes
			Shanta Dhar, PhD.                                        Assistant Professor of Chemistry University of Georgia Athens, GA, USA Title: HDL-mimicking nanoparticles for atherosclerosis

* Presenting Speaker names, title and times are subject to change.
Host organization, organizer, or scientific committee does not take any kind of responsibility.

Target Audience:

Presidents, CEOs, CSOs and other Management Professionals
Professors, Post docs, and Graduate students from Academia
R & D Scientists from Biotech & Pharma Industry
Clinical Fellows, Residents & Nurses from Health Care Industry
Business Development & Marketing Professionals
Investment, Technology Acquisition Portfolio Managers

Advantages of Attending this Event:

Gain an up-to-date in-depth knowledge of diabetes, obesity & cardio-vascular diseases
Understand the molecular orchestra between diabetes, obesity and other metabolic diseases
Network with senior scientists, management people representing from academia and industry
Develop academic and business collaborations with academicians and pharmaceutical leaders
Exhibit and show case your new products and devices

Exhibitors are welcome to reserve their booth space early!

Please contact if you are interested in speaking in the scientific or Technology workshops of this meeting.

GeneExpression Systems, Inc.
P.O. Box 540170
Waltham, MA 02454 USA
Tel: (781) 891-8181
Fax: (781) 730-0700 or (781) 891-8234
E-mail: Genexpsys@expressgenes.com
www.expressgenes.com

Note: Speakers Names, Titles and venue subjected to change beyond our control for which the company is not responsible.

For Oral Presentation Abstracts Due By: June 10, 2013
For Poster Presentation Abstracts Due By: June 30, 2013